Current Ratio of Insight Molecular Diagnostics Inc. from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Insight Molecular Diagnostics Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • Insight Molecular Diagnostics Inc. Current Ratio for the quarter ending 30 Sep 2025 was 308%, a 206% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Insight Molecular Diagnostics Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 308% +207% +206% 30 Sep 2025
Q2 2025 244% +100% +70% 30 Jun 2025
Q1 2025 189% +12% +6.9% 31 Mar 2025
Q4 2024 104% -95% -48% 31 Dec 2024
Q3 2024 101% -112% -53% 30 Sep 2024
Q2 2024 143% -91% -39% 30 Jun 2024
Q1 2024 177% -85% -32% 31 Mar 2024
Q4 2023 199% -57% -22% 31 Dec 2023
Q3 2023 212% -59% -22% 30 Sep 2023
Q2 2023 234% -55% -19% 30 Jun 2023
Q1 2023 261% -2% -0.78% 31 Mar 2023
Q4 2022 256% -94% -27% 31 Dec 2022
Q3 2022 271% -56% -17% 30 Sep 2022
Q2 2022 289% +6% +2.1% 30 Jun 2022
Q1 2022 264% -34% -11% 31 Mar 2022
Q4 2021 350% +168% +92% 31 Dec 2021
Q3 2021 327% +63% +24% 30 Sep 2021
Q2 2021 283% -93% -25% 30 Jun 2021
Q1 2021 298% -235% -44% 31 Mar 2021
Q4 2020 182% -640% -78% 31 Dec 2020
Q3 2020 264% -411% -61% 30 Sep 2020
Q2 2020 376% -190% -34% 30 Jun 2020
Q1 2020 533% +125% +31% 31 Mar 2020
Q4 2019 823% +594% +260% 31 Dec 2019
Q3 2019 674% +433% +180% 30 Sep 2019
Q2 2019 565% +321% +132% 30 Jun 2019
Q1 2019 408% +173% +73% 31 Mar 2019
Q4 2018 228% -16% -6.4% 31 Dec 2018
Q3 2018 241% -28% -11% 30 Sep 2018
Q2 2018 244% -52% -18% 30 Jun 2018
Q1 2018 236% -69% -23% 31 Mar 2018
Q4 2017 244% -60% -20% 31 Dec 2017
Q3 2017 269% -70% -21% 30 Sep 2017
Q2 2017 296% 30 Jun 2017
Q1 2017 304% 31 Mar 2017
Q4 2016 304% 31 Dec 2016
Q3 2016 339% 30 Sep 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.